Product information and disease descriptionPlace of product in therapyApproaches to treatment
Heterogeneity of treatment effect
1 evidence topic · 1 source
Tirabrutinib
Primary central nervous system lymphoma
- Manufacturer
- Deciphera Pharmaceuticals
- Regulatory submission
- NDA submitted December 2025
- Last updated